Radiopharm Theranostics Limited
Price Action
Technical Summary
DOWNTRENDRadiopharm Theranostics Limited is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 23), showing significant lag compared to the market leaders. Investors should exercise caution due to high volatility (93% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.50 | -7.88% | BELOW |
| 50 SMA | $4.59 | -9.67% | BELOW |
| 100 SMA | $4.89 | -15.15% | BELOW |
| 150 SMA | $5.04 | -17.58% | BELOW |
| 200 SMA | $5.16 | -19.65% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is RADX in an uptrend right now?
RADX has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.
Is RADX overbought or oversold?
RADX's RSI (14) is 41. The stock is in neutral territory, neither overbought nor oversold.
Is RADX outperforming the market?
RADX has a Relative Strength (RS) Rating of 23 out of 99. RADX is currently lagging the broader market.
Where is RADX in its 52-week range?
RADX is trading at $4.15, which is 26% of its 52-week high ($16.25) and 4% above its 52-week low ($3.62).
How volatile is RADX?
RADX has a Beta of 0.88 and 52-week volatility of 93%. It's less volatile than the S&P 500 - generally more stable.